229 related articles for article (PubMed ID: 7860746)
1. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure.
Duerr RL; Huang S; Miraliakbar HR; Clark R; Chien KR; Ross J
J Clin Invest; 1995 Feb; 95(2):619-27. PubMed ID: 7860746
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of insulin-like growth factor-1 and growth hormone in chronic left ventricular failure in the rat.
Duerr RL; McKirnan MD; Gim RD; Clark RG; Chien KR; Ross J
Circulation; 1996 Jun; 93(12):2188-96. PubMed ID: 8925588
[TBL] [Abstract][Full Text] [Related]
3. The role of hypertrophy and growth factors in heart failure.
Ross J; Hongo M
J Card Fail; 1996 Dec; 2(4 Suppl):S121-8. PubMed ID: 8951569
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction.
Cittadini A; Grossman JD; Napoli R; Katz SE; Strömer H; Smith RJ; Clark R; Morgan JP; Douglas PS
J Am Coll Cardiol; 1997 Apr; 29(5):1109-16. PubMed ID: 9120168
[TBL] [Abstract][Full Text] [Related]
5. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
[TBL] [Abstract][Full Text] [Related]
6. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation.
Cittadini A; Strömer H; Katz SE; Clark R; Moses AC; Morgan JP; Douglas PS
Circulation; 1996 Feb; 93(4):800-9. PubMed ID: 8641010
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition.
Jin H; Yang R; Gillett N; Clark RG; Ko A; Paoni NF
J Cardiovasc Pharmacol; 1995 Sep; 26(3):420-5. PubMed ID: 8583784
[TBL] [Abstract][Full Text] [Related]
8. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
10. Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction.
Tivesten A; Caidahl K; Kujacic V; Sun XY; Hedner T; Bengtsson BA; Isgaard J
Growth Horm IGF Res; 2001 Jun; 11(3):187-95. PubMed ID: 11735233
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone improves cardiac function in rats with experimental myocardial infarction.
Isgaard J; Kujacic V; Jennische E; Holmäng A; Sun XY; Hedner T; Hjalmarson A; Bengtsson BA
Eur J Clin Invest; 1997 Jun; 27(6):517-25. PubMed ID: 9229233
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.
Brower GL; Janicki JS
J Card Fail; 2005 Sep; 11(7):548-56. PubMed ID: 16198252
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone attenuates skeletal muscle changes in experimental chronic heart failure.
Santos DP; Okoshi K; Moreira VO; Seiva FR; Almeida FL; Padovani CR; Carvalho RF; Okoshi MP; Cicogna AC; Castro AV; Pai-Silva MD
Growth Horm IGF Res; 2010 Apr; 20(2):149-55. PubMed ID: 20060348
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human growth hormone secreted from tissue-engineered bioartificial muscle improves left ventricular function in rat with acute myocardial infarction.
Rong SL; Wang YJ; Wang XL; Lu YX; Chang C; Wang FZ; Liu QY; Liu XY; Gao YZ; Mi SH
Chin Med J (Engl); 2009 Oct; 122(19):2352-9. PubMed ID: 20079139
[TBL] [Abstract][Full Text] [Related]
15. Increased insulin-like growth factor-I gene expression precedes left ventricular cardiomyocyte hypertrophy in a rapidly-hypertrophying rat model system.
Huang CY; Buchanan DL; Gordon RL; Sherman MJ; Razzaq J; White K; Buetow DE
Cell Biochem Funct; 2003 Dec; 21(4):355-61. PubMed ID: 14624474
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
17. Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice.
Tanaka N; Ryoke T; Hongo M; Mao L; Rockman HA; Clark RG; Ross J
Am J Physiol; 1998 Aug; 275(2):H393-9. PubMed ID: 9683425
[TBL] [Abstract][Full Text] [Related]
18. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction.
Dai W; Wold LE; Dow JS; Kloner RA
J Am Coll Cardiol; 2005 Aug; 46(4):714-9. PubMed ID: 16098441
[TBL] [Abstract][Full Text] [Related]
19. Recombinant proteins secreted from tissue-engineered bioartificial muscle improve cardiac dysfunction and suppress cardiomyocyte apoptosis in rats with heart failure.
Rong SL; Wang YJ; Wang XL; Lu YX; Wu Y; Liu QY; Mi SH; Xu YL
Chin Med J (Engl); 2010 Dec; 123(24):3626-2633. PubMed ID: 22166642
[TBL] [Abstract][Full Text] [Related]
20. Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
Litwin SE; Katz SE; Morgan JP; Douglas PS
Br J Pharmacol; 1999 Aug; 127(7):1671-9. PubMed ID: 10455325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]